AMPH logo

AMPH Amphastar Pharmaceuticals, Inc.

NASDAQ Global Select · Drug Manufacturers - Specialty & Generic · Healthcare

$28.89
-0.82 (-2.78%)

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United S…

Market Cap: $1.23Bwww.amphastar.com

Price

No data yet.

Social Signal Score

54
5d
—
30d
53
6 mentions
—
60d
56
7 mentions
—
90d
54
9 mentions
—
news: 9

Analyst Ratings

12 analysts
Holdconsensus
Strong Buy 0Buy 3Hold 8Sell 1Strong Sell 0
Avg price target$23-20.4%
Low $23Median $23High $23
Current Consensus

Revenue

$207.61M+226.72%
$56.67M$106.98M$157.30M$207.61M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$3.44
$3.40–$3.47
5 analysts
FY2026
$3.20-7% YoY
$2.89–$3.40
3 analysts
FY2027
$3.35+5% YoY
$3.07–$3.55
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Yongfeng Zhang
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,976
Beta
0.94
Country
US
Piotroski score
6 / 9 (Middling)
Altman Z-score
2.49
www.amphastar.com